| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Jun 3, 2025 | HAEMONETICS CORP | EVP and General Counsel | Sell | 97.5 | +8,085 | 23.66% | ✗ | $518.2K |
| May 15, 2025 | May 19, 2025 | HAEMONETICS CORP | EVP and General Counsel | Sell | 22.5 | -2,779 | -8.89% | ✗ | $194.8K |
| May 28, 2024 | May 29, 2024 | HAEMONETICS CORP | EVP and General Counsel | Sell | 48.8 | - | 0.00% | ✓ | $2.3M |
| May 17, 2024 | May 21, 2024 | HAEMONETICS CORP | EVP and General Counsel | Sell | 90.0 | +832 | 2.73% | ✓ | $318.5K |
| May 15, 2024 | May 17, 2024 | HAEMONETICS CORP | EVP and General Counsel | Sell | 32.5 | -1,847 | -5.72% | ✓ | $177.1K |
| Oct 20, 2023 | Oct 24, 2023 | HAEMONETICS CORP | EVP and General Counsel | Sell | 36.3 | -197 | -0.61% | ✗ | $17.5K |
| May 18, 2023 | May 19, 2023 | HAEMONETICS CORP | EVP and General Counsel | Sell | 20.0 | -3,541 | -9.83% | ✗ | $295.1K |
| May 15, 2023 | May 17, 2023 | HAEMONETICS CORP | EVP and General Counsel | Sell | 91.3 | +3,759 | 11.66% | ✗ | $39.8K |
| May 12, 2023 | May 16, 2023 | HAEMONETICS CORP | EVP and General Counsel | Sell | 36.3 | -204 | -0.63% | ✗ | $18K |
| Oct 24, 2022 | Oct 26, 2022 | HAEMONETICS CORP | EVP and General Counsel | Sell | 48.8 | -180 | -0.55% | ✗ | $14.5K |
| Sep 19, 2022 | Sep 21, 2022 | HAEMONETICS CORP | EVP and General Counsel | Sell | 7.5 | -11,448 | -25.97% | ✓ | $897.1K |
| Sep 15, 2022 | Sep 19, 2022 | HAEMONETICS CORP | EVP and General Counsel | Sell | 5.0 | -33,798 | -48.85% | ✓ | $2.6M |
| Jun 13, 2022 | Jun 15, 2022 | HAEMONETICS CORP | EVP and General Counsel | Sell | 48.8 | -277 | -0.68% | ✗ | $17.3K |
| May 19, 2022 | May 23, 2022 | HAEMONETICS CORP | EVP and General Counsel | Sell | 42.5 | -3,258 | -7.38% | ✗ | $192.5K |
| May 16, 2022 | May 18, 2022 | HAEMONETICS CORP | EVP and General Counsel | Sell | 91.3 | +5,880 | 15.36% | ✗ | $11K |
| Oct 25, 2021 | Oct 27, 2021 | HAEMONETICS CORP | EVP and General Counsel | Sell | 52.5 | -120 | -0.31% | ✗ | $8.6K |
| Jun 14, 2021 | Jun 16, 2021 | HAEMONETICS CORP | EVP and General Counsel | Sell | 48.8 | -195 | -0.51% | ✗ | $11.7K |
| Jun 7, 2021 | Jun 9, 2021 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -442 | -1.13% | ✗ | $24.3K |
| May 18, 2021 | May 20, 2021 | HAEMONETICS CORP | EVP and General Counsel | Sell | 91.3 | +23,644 | 153.50% | ✗ | $12.1K |
| May 17, 2021 | May 18, 2021 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -204 | -1.31% | ✗ | $11.4K |
| Mar 8, 2021 | Mar 10, 2021 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -385 | -2.41% | ✗ | $46.2K |
| Oct 23, 2020 | Oct 26, 2020 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -181 | -1.12% | ✗ | $19.3K |
| Jun 12, 2020 | Jun 16, 2020 | HAEMONETICS CORP | EVP and General Counsel | Sell | 40.0 | -203 | -1.24% | ✓ | $2.2M |
| Jun 8, 2020 | Jun 10, 2020 | HAEMONETICS CORP | EVP and General Counsel | Sell | 42.5 | -687 | -4.03% | ✗ | $66.7K |
| May 15, 2020 | May 19, 2020 | HAEMONETICS CORP | EVP and General Counsel | Sell | 91.3 | +2,699 | 18.79% | ✗ | $20.4K |
| Mar 9, 2020 | Mar 10, 2020 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -395 | -2.68% | ✗ | $38.7K |
| Oct 8, 2019 | Oct 10, 2019 | HAEMONETICS CORP | EVP and General Counsel | Sell | 5.0 | -19,516 | -59.77% | ✓ | $2.4M |
| Jun 12, 2019 | Jun 13, 2019 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -231 | -1.73% | ✗ | $25.3K |
| Jun 6, 2019 | Jun 10, 2019 | HAEMONETICS CORP | EVP and General Counsel | Sell | 10.0 | -13,335 | -23.73% | ✓ | $1.4M |
| Mar 7, 2019 | Mar 11, 2019 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -391 | -2.95% | ✗ | $32.7K |
| Jun 7, 2018 | Jun 8, 2018 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -457 | -4.13% | ✗ | $42.4K |
| Mar 6, 2018 | Mar 8, 2018 | HAEMONETICS CORP | EVP and General Counsel | Sell | 46.3 | -389 | -3.48% | ✗ | $28.1K |